Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Replicate Seeding Density Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 3.00 6184.25 0.0005 -0.9693
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 3.00 6184.25 0.0005 -0.9693
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 2.00 6184.25 0.0003 -0.9754
SK-BR-3
0
uM
8 5000.00 1743.19 3.00 6184.25 0.0005 -0.9693
SK-BR-3
0
uM
8 5000.00 1743.19 3.00 6184.25 0.0005 -0.9693
BT-20
0
uM
9 156.25 71.09 82.00 119.00 0.6891 0.2118
BT-20
0
uM
9 156.25 71.09 140.00 119.00 1.1765 1.4888
BT-20 Erlotinib
0.0033113
uM
9 156.25 71.09 75.00 119.00 0.6303 0.0747
BT-20 17-AAG
0.001
uM
9 156.25 71.09 137.00 119.00 1.1513 1.4173
BT-20 17-AAG
0.000066069
uM
9 156.25 71.09 182.00 119.00 1.5294 2.5425
BT-20 Linsitinib
3.1623
uM
9 156.25 71.09 139.00 119.00 1.1681 1.4649
BT-20 Erlotinib
19.9526
uM
9 156.25 71.09 193.00 119.00 1.6218 2.8335
BT-20 Lapatinib
0.1
uM
9 156.25 71.09 144.00 119.00 1.2101 1.5850
BT-20 Lapatinib
0.0016596
uM
9 156.25 71.09 180.00 119.00 1.5126 2.4902
BT-20
0
uM
9 156.25 71.09 168.00 119.00 1.4118 2.1808